Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (241-250 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|May 18, 2016
Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulatorAmandeep K Gakhal, Timothy J Jensen, Zoltan Bozoky, et al.
Mabs|May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesLindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Mabs|May 24, 2016
Structural diversity in a human antibody germline libraryAlexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Mabs|June 9, 2016
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, FranceGuillaume Desoubeaux, Janice M Reichert, Matthew Sleeman, et al.
Mabs|November 10, 2017
Enhancing antibody patent protection using epitope mapping informationXiaoxiang Deng, Ulrich Storz, Benjamin J Doranz
Mabs|December 5, 2017
Assessment of structural and functional similarity of biosimilar products: Rituximab as a case studyNeh Nupur, Nidhi Chhabra, Rozaleen Dash, et al.
Mabs|September 13, 2017
Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn bindingAdam Zwolak, Anthony A Armstrong, Susan H Tam, et al.
Mabs|October 17, 2017
Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologicsZhaoyang Li, Rachael Easton
Mabs|July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myelomaAlex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Mabs|March 11, 2016
Length-independent structural similarities enrich the antibody CDR canonical class modelJaroslaw Nowak, Terry Baker, Guy Georges, et al.
Pageof 184

Showing results (241-250 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|May 18, 2016
Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulatorAmandeep K Gakhal, Timothy J Jensen, Zoltan Bozoky, et al.
Mabs|May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesLindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Mabs|May 24, 2016
Structural diversity in a human antibody germline libraryAlexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Mabs|June 9, 2016
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, FranceGuillaume Desoubeaux, Janice M Reichert, Matthew Sleeman, et al.
Mabs|November 10, 2017
Enhancing antibody patent protection using epitope mapping informationXiaoxiang Deng, Ulrich Storz, Benjamin J Doranz
Mabs|December 5, 2017
Assessment of structural and functional similarity of biosimilar products: Rituximab as a case studyNeh Nupur, Nidhi Chhabra, Rozaleen Dash, et al.
Mabs|September 13, 2017
Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn bindingAdam Zwolak, Anthony A Armstrong, Susan H Tam, et al.
Mabs|October 17, 2017
Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologicsZhaoyang Li, Rachael Easton
Mabs|July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myelomaAlex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Mabs|March 11, 2016
Length-independent structural similarities enrich the antibody CDR canonical class modelJaroslaw Nowak, Terry Baker, Guy Georges, et al.
Pageof 184